About
Alentar is developing therapies that reverse goblet cell hyperplasia to treat cystic fibrosis and other pulmonary diseases.
Explore Alentar's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Alentar is developing therapies that reverse goblet cell hyperplasia to treat cystic fibrosis and other pulmonary diseases.
Funding rounds, investor list, and risk signals — unlock with a subscription.